Interleukin-4 downregulates interleukin-6 production in human peripheral blood mononuclear cells

J Leukoc Biol. 1990 May;47(5):475-9. doi: 10.1002/jlb.47.5.475.

Abstract

We report that recombinant human interleukin-4 (IL-4) downregulates interleukin-6 (IL-6) production by human peripheral blood mononuclear cells (PBMC). PBMC were preincubated for up to 24 hr in the presence of IL-4 (100 U/ml) and then activated with lipopolysaccharide B Escherichia coli 026:B6 (LPS, 10 micrograms/ml), recombinant human tumor necrosis factor-alpha (TNF-alpha, 200 U/ml), or Concanavalin A (Con A, 10 micrograms/ml). Although all these signals induced IL-6 production, IL-4-treated cells produced significantly reduced levels of IL-6 protein. This effect was dose and time dependent. We conclude that IL-4 is a potent downregulatory modulator of IL-6 expression in human PBMC.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cells, Cultured
  • Concanavalin A / pharmacology
  • Dose-Response Relationship, Drug
  • Down-Regulation / drug effects*
  • Down-Regulation / physiology
  • Humans
  • Interleukin-4 / pharmacology*
  • Interleukin-4 / physiology
  • Interleukin-6 / metabolism*
  • Lipopolysaccharides / pharmacology
  • Monocytes / metabolism*
  • Time Factors
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Interleukin-6
  • Lipopolysaccharides
  • Tumor Necrosis Factor-alpha
  • Concanavalin A
  • Interleukin-4